Rechallenge with oxaliplatin and peripheral neuropathy in colorectal cancer patients

ConclusionRetreatment with OXA in CRC patients is a feasible option even in patients who previously developed moderate or severe OIN. One-third of patients ’ OIN was worsened by retreatment. Neurological monitoring should be considered.
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research